PIOMBINO DESE, Italy--(BUSINESS WIRE)--Stevanato Group S.p.A. (NYSE: STVN) a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, ...

LONDON (Reuters) - Makers of inhalers to treat asthma and chronic lung disease are racing to develop a new generation of smart devices with sensors to monitor if patients are using their puffers ...

BOONE, N.C.--(BUSINESS WIRE)--Pneuma Respiratory, a leader in inhaled respiratory therapeutics, today announced the results of a groundbreaking study examining the aerosol composition of various ...

The American Thoracic Society (ATS) and Sunovion Pharmaceuticals Inc. (Sunovion) today announced the results of a survey of pulmonologists and pulmonology fellows to determine physicians’ knowledge, ...

Inhalers are the mainstay of treatment for asthma and chronic obstructive pulmonary disease (COPD). These products face limited generic competition in the US and remain expensive. To better understand ...

Molex LLC, parent to medical supplier Phillips-Medisize LLC, has signed an agreement through its Molex Asia Holdings Ltd. affiliate to acquire Vectura Group Ltd. from Vectura Fertin Pharma Inc., a ...

The characteristics of an ideal inhaler are based around the design and formulation of the device, patient use and the clinical effect, together with concordance and patient preference. To ensure ...

The global inhalation CDMO market is projected to expand from USD 9.13 billion in 2025 to USD 16.68 billion by 2035, reflecting a steady compound annual growth rate (CAGR) of 5.7% over the forecast ...